Piramal Swasthya Management and ResearchInstitute, the primary healthcare initiative of Piramal Foundation, and The Rockefeller Foundation today announced a strategic partnership to align with and support the Government of India’s vision to ensure Universal Health Coverage. In the initial stages, the partnership aims to set a global example by leveraging digital technology to reduce preventable deaths amongst mothers and children living in Aspirational Districts and tribal areas.
The Piramal Swasthya and Rockefeller teams will be working closely with the government on building cutting-edge primary health innovations and scaling them through policy interventions. The partnership will strengthen healthcare systems by integrating technologies such as artificial intelligence for evidence-based decision making. The idea is to save maternal and child deaths by providing appropriate and timely insights leading to effective policymaking and implementation of focused interventions.
The Piramal-Rockefeller partnership focuses on five of the 25 Aspirational Districts that are mentored by NITI Aayog. They are also part of the 117 Aspirational Districts identified by the Government of India as having urgent health and development needs. Many residents of these districts are members of tribal populations, who have significantly worse health outcomes than non-tribal populations. The maternal mortality rate in India is 122 deaths per 100,000 live births, while in the tribal communities it is even higher. Similarly, other health indicators such as infant mortality rates, child malnutrition rates, and incidence of malaria and tuberculosis are much higher among tribal communities than the general population.
At the outset, the PiramalRockefeller partnership will focus on two main streams of work:
この記事は Express Pharma の January 1-15, 2020 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です ? サインイン
この記事は Express Pharma の January 1-15, 2020 版に掲載されています。
7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。
すでに購読者です? サインイン
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation
